biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Dec 21, 2022 5:58pm

170 Views

Post# 35185882

The volume has settled down and the stock was up today

The volume in Canada was only 66,900 shares today.

Only 3 trading days left for tax loss selling.

The stock has been washed out and now to echo Midatech's CEO is it time for those who see perhaps the biggest opportunity set in biotech for a company this size to step forward? The massive dilution came with massive and rare upside but those who wear personal failure may have hard time looking up to see the blue sky. Emotional investors like KayackerBC are also often a contrary indicator. His sales may mark the 'Great KayackerBC Bottom'.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price